IGF-I 24-41
CAS No. 135861-49-3
IGF-I 24-41( Insulin-like Growth Factor I (24-41) )
Catalog No. M29823 CAS No. 135861-49-3
IGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameIGF-I 24-41
-
NoteResearch use only, not for human use.
-
Brief DescriptionIGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).
-
DescriptionIGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).
-
In Vitro——
-
In VivoIGF-I (24-41) (ICV; 200 ng dose; 2 μL; postnatal days 2, 4, and 7) regulates somatic growth and behavioral development. Animal Model:Mice of an outbred Swiss-derived strain (CD-l) weighing 30-33g (virgin males) or 28-30g (nulliparous females)Dosage:200 ng dose; 2 μL Administration:ICV; postnatal days (PND) 2, 4, and 7 Result:Increased the rate of ultrasonic calls of the pups measured on PND8.
-
SynonymsInsulin-like Growth Factor I (24-41)
-
PathwayAngiogenesis
-
TargetIGF-1R
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number135861-49-3
-
Formula Weight2017.16
-
Molecular FormulaC88H133N27O28
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (24.79 mM助)
-
SMILES——
-
Chemical NameSequence:{Tyr}{Phe}{Asn}{Lys}{Pro}{Thr}{Gly}{Tyr}{Gly}{Ser}{Ser}{Ser}{Arg}{Arg}{Ala}{Pro}{Gln}{Thr}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Puche JE, et al. Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J Transl Med. 2012 Nov 14;10:224.
molnova catalog
related products
-
Ganitumab
Ganitumab (AMG 479) is a highly potent monoclonal antibody targeting the type 1 insulin-like growth factor receptor (IGF1R). Recognized for binding IGF1R at low concentrations with a KD value of 0.22 nM, Ganitumab inhibits IGF1R interactions with IGF1 and IGF2 in mice, making it useful for cancer research.
-
CTLA-4 inhibitor
CTLA-4 inhibitor is a potent CTLA-4 inhibitor.
-
GSK1904529A
GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM.
Cart
sales@molnova.com